ANAPTYSBIO, INC 10-Q filing
Filed 2026-05-12 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-219515
- Form type
- 10-Q
- CIK
- 0001370053
- Primary document
- https://www.sec.gov/Archives/edgar/data/1370053/000119312526219515/anab-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ANAPTYSBIO, INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $25.6M | - | - |
| Operating Income | $-34.6M | - | - |
| Net Income | $-52.9M | - | - |
| Eps Basic | -1.84 | - | - |
| Eps Diluted | -1.84 | - | - |
| Cash And Equivalents | $248.5M | - | - |
| Total Assets | $329.7M | - | - |
| Shareholders Equity | $12.7M | - | - |
| Operating Cash Flow | $-25.9M | - | - |
| Capital Expenditures | $17,000 | - | - |